My Calendar

Name: R&D Productivity Metrics
Start: 2024-12-25T17:30:00-08:00
End: 2024-12-25T18:30:00-08:00

Events in December 2024

Mon	Tue	Wed	Thu	Fri

2	3 10:30 am: Country Analytics and Optimization Country Analytics and Optimization 10:30 am - 11:30 am Country level analytics are essential for understanding how the timeline for your trial will unfold. This webinar highlights key performance analytics and KMR proprietary advanced statistics used to evaluate country performance while highlighting the importance of using a trusted data source and the details around the data used to compile country level analytics, i.e., it needs to be derived from the country. REGISTER 5:30 pm: Country Analytics and Optimization Country Analytics and Optimization 5:30 pm - 6:30 pm Country level analytics are essential for understanding how the timeline for your trial will unfold. This webinar highlights key performance analytics and KMR proprietary advanced statistics used to evaluate country performance while highlighting the importance of using a trusted data source and the details around the data used to compile country level analytics, i.e., it needs to be derived from the country. REGISTER	4 10:30 am: R&D Advantage Report: Key Productivity Metrics for R&D R&D Advantage Report: Key Productivity Metrics for R&D 10:30 am - 11:30 am Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. REGISTER 5:30 pm: R&D Advantage Report: Key Productivity Metrics for R&D R&D Advantage Report: Key Productivity Metrics for R&D 5:30 pm - 6:30 pm Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. REGISTER	5 10:30 am: Trial Cost Analytics - Benchmarks, Productivity & Predictive Models Trial Cost Analytics - Benchmarks, Productivity & Predictive Models 10:30 am - 11:30 am Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. REGISTER 5:30 pm: Trial Cost Analytics - Benchmarks, Productivity & Predictive Models Trial Cost Analytics - Benchmarks, Productivity & Predictive Models 5:30 pm - 6:30 pm Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. REGISTER	6
9	10 3:30 am: 2022 R&D General Metrics Presentation (Participants Only) - Europe (CEST 9:30 am) 2022 R&D General Metrics Presentation (Participants Only) - Europe (CEST 9:30 am) 3:30 am - 6:00 am R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 10:30 am: Clinical Cycle Time Program: Establishing A Framework For Company Performance Clinical Cycle Time Program: Establishing A Framework For Company Performance 10:30 am - 11:30 am Measuring the performance of clinical trials requires a solid framework of how and what to measure. Join this webinar to learn about the key metrics used to evaluate clinical trial cycle times and how to benchmark your performance. Learn too about KMR proprietary advanced scoring and ranking methods to help normalize for protocol complexity and more. REGISTER 12:30 pm: 2022 R&D General Metrics Presentation (Participants Only) - US Pacific (PDT 9:30am) 2022 R&D General Metrics Presentation (Participants Only) - US Pacific (PDT 9:30am) 12:30 pm - 3:00 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 5:30 pm: Clinical Cycle Time Program: Establishing A Framework For Company Performance Clinical Cycle Time Program: Establishing A Framework For Company Performance 5:30 pm - 6:30 pm Measuring the performance of clinical trials requires a solid framework of how and what to measure. Join this webinar to learn about the key metrics used to evaluate clinical trial cycle times and how to benchmark your performance. Learn too about KMR proprietary advanced scoring and ranking methods to help normalize for protocol complexity and more. REGISTER 8:30 pm: 2022 R&D General Metrics Presentation (Participants Only) - Japan (JST 9:30 am Next Day) 2022 R&D General Metrics Presentation (Participants Only) - Japan (JST 9:30 am Next Day) 8:30 pm - 11:00 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER	11 10:30 am: Enrollment Planning Analytics Enrollment Planning Analytics 10:30 am - 11:30 am Quality data, the right analytics and the application of those analytics can be instrumental in getting trials completed more quickly and more effectively. Join us to better understand the essential metrics for your planning needs and the nuances in getting the data right. REGISTER 5:30 pm: Enrollment Planning Analytics Enrollment Planning Analytics 5:30 pm - 6:30 pm Quality data, the right analytics and the application of those analytics can be instrumental in getting trials completed more quickly and more effectively. Join us to better understand the essential metrics for your planning needs and the nuances in getting the data right. REGISTER	12 3:30 am: 2022 R&D General Metrics Presentation (Participants Only) - Europe (CEST 9:30 am) 2022 R&D General Metrics Presentation (Participants Only) - Europe (CEST 9:30 am) 3:30 am - 6:00 am R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 10:00 am: 2022 R&D General Metrics Presentation (Participants Only) - US Central (CDT 9:00am) 2022 R&D General Metrics Presentation (Participants Only) - US Central (CDT 9:00am) 10:00 am - 12:30 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 10:00 am: 2022 R&D General Metrics Presentation (Participants Only) - US Central (CDT 9:00am) 2022 R&D General Metrics Presentation (Participants Only) - US Central (CDT 9:00am) 10:00 am - 12:30 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 12:30 pm: 2022 R&D General Metrics Presentation (Participants Only) - US Pacific (PDT 9:30am) 2022 R&D General Metrics Presentation (Participants Only) - US Pacific (PDT 9:30am) 12:30 pm - 3:00 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER 8:30 pm: 2022 R&D General Metrics Presentation (Participants Only) - Japan (JST 9:30 am Next Day) 2022 R&D General Metrics Presentation (Participants Only) - Japan (JST 9:30 am Next Day) 8:30 pm - 11:00 pm R&D Key Performance Metrics on R&D, Discovery and Development. This comprehensive presentation covers Productivity, Success Rates, Cycle Times, Value, Pipeline and Resources. The session includes new findings, trends, statistical analysis on key drivers and valuable insights into what is driving R&D performance and including NEW Covid impacts. Open to study participants only. Contact us for further information. REGISTER	13
16	17	18 10:30 am: Site Contracts Site Contracts 10:30 am - 11:30 am This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. REGISTER 5:30 pm: Site Contracts Site Contracts 5:30 pm - 6:30 pm This webinar will address site contract cycle time benchmarks to help inform you on the time it takes to get a site ready to enroll. We will talk about the differences across companies, site type, disease, geography (global, country, region) and outsourcing. REGISTER	19 10:30 am: Measuring and Improving R&D Success Rates Measuring and Improving R&D Success Rates 10:30 am - 11:30 am Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing success rates. Plus an overview of how to create more nuanced risk based performance models using deep learning methods. REGISTER 5:30 pm: Measuring and Improving R&D Success Rates Measuring and Improving R&D Success Rates 5:30 pm - 6:30 pm Calculating and interpreting success rates is extremely complex and requires a deep understanding of drug development and risk. This session outlines some of the essentials that go into a robust assessment of success based on our long history measuring, evaluating and developing success rates. Plus an overview of how to create more nuanced risk based performance models using deep learning methods. REGISTER	20
23	24 10:30 am: Site Selection Using Advanced Analytics Site Selection Using Advanced Analytics 10:30 am - 11:30 am Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. Easier said than done. Learn the details around what it takes to evaluate named site performance from standardizing site information to creating performance scores including KMR’s proprietary 5 Star Rankings. REGISTER 5:30 pm: Site Selection Using Advanced Analytics Site Selection Using Advanced Analytics 5:30 pm - 6:30 pm Companies in the know are relying on peerless data and advanced analytics to drive their site selection practices. Easier said than done. Learn the details around what it takes to evaluate named site performance from standardizing site information to creating performance scores including KMR’s proprietary 5 Star Rankings. REGISTER	25 10:30 am: R&D Productivity Metrics R&D Productivity Metrics 10:30 am - 11:30 am Measuring R&D Productivity goes beyond simply counting NME approvals and dividing by spending although that is a valid and key way to assess performance. In addition to basic productivity metrics, we present a variety of both leading and lagging productivity indicators to assess both output and value of R&D performance. REGISTER 5:30 pm: R&D Productivity Metrics R&D Productivity Metrics 5:30 pm - 6:30 pm Measuring R&D Productivity goes beyond simply counting NME approvals and dividing by spending although that is a valid and key way to assess performance. In addition to basic productivity metrics, we present a variety of both leading and lagging productivity indicators to assess both output and value of R&D performance. REGISTER	26	27
30	31